Search results (103)
« Back to News300 companies created by the University of Oxford
29 March 2023
The University of Oxford has reached the milestone of creating 300 companies based on research and ideas from students, staff and alumni.
The women founders contributing to Oxford’s spinout success
8 March 2023
More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.
NICE recommends digital mental health technologies from Oxford
8 February 2023
Two digital tools were recommended for use in the NHS to help children and young people with symptoms of anxiety or low mood.
Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
1 February 2023
Clinical Trials General Innovation Research
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
Significant scale-up investment for three Oxford spinouts
16 January 2023
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Oxford Innovation Society celebrates pioneering biomedical research and innovation
10 October 2022
Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.
Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
3 October 2022
Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.
Oxford spinout MiroBio acquired by Gilead Sciences for $405m
4 August 2022
The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.
Oxford to receive £7 million to turn bright ideas into global opportunities
15 June 2022
Awards and Appointments General Innovation
The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.
Oxford expands the Cartography collaboration with Janssen
6 June 2022
The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
6 April 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
Oxford University retains top spot for spinout generation in the UK
4 April 2022
Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.
The glass half full man: Professor Chas Bountra and Oxford's innovative future
1 April 2022
Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.
Exscientia and University of Oxford launch “Xcellomics” program to expedite early-stage academic research and translate novel biology into future drug discovery
10 March 2022
Exscientia and the University of Oxford's Target Discovery Institute (TDI) today announced the formation of Xcellomics – a program designed to source cellular functional assays from the global academic community to develop novel screens and identify targets and therapeutic candidates for unmet medical needs.
Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021
2 March 2022
Awards and Appointments General Innovation Research
Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.
Sir Jon Symonds joins Pharmacology as a Visiting Fellow
14 February 2022
Awards and Appointments General Innovation
The Department of Pharmacology is delighted to announce the appointment of Sir Jonathan Symonds CBE, Chair of the Board of GlaxoSmithKline, as a Visiting Fellow. Jon has been Chairman of the Board at GSK since September 2019.
Medical Sciences welcomes Steve Bates as Royal Society Entrepreneur in Residence
3 February 2022
Awards and Appointments General Innovation
The Medical Sciences Division welcomes Steve Bates, CEO of the UK Bioindustry Association, as a Royal Society Entrepreneur in Residence. Steve Bates will be working very closely with our Translational Research Office and key teams across the University of Oxford's innovation ecosystem.
New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
3 December 2021
GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.
Jenner Institute named Covid Innovation Heroes
26 November 2021
Awards and Appointments General Innovation
The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award 2021.
Oxford joins consortium to advance quantum drug discovery with £6.8M grant from Innovate UK
5 November 2021
Oxford University today joins a consortium led by the digital quantum computing company, SEEQC, to build and deliver a full-stack quantum computer for pharmaceutical drug development for Merck KGaA.